METABOLISM OF NOMIFENSINE AFTER ORAL AND INTRAVENOUS ADMINISTRATION

被引:16
作者
LINDBERG, RLP
SYVALAHTI, EKG
机构
关键词
D O I
10.1038/clpt.1986.58
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:378 / 383
页数:6
相关论文
共 15 条
[1]  
CHAN KK, 1982, DRUG METAB DISPOS, V10, P474
[2]   FURTHER ASPECTS OF NOMIFENSINE PHARMACOLOGY [J].
COSTALL, B ;
NAYLOR, RJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 :S89-S99
[3]  
HEPTNER W, 1984, J CLIN PSYCHIAT, V45, P21
[4]  
HEPTNER W, 1978, ARZNEIMITTEL-FORSCH, V28-1, P58
[5]   METABOLISM OF NOMIFENSINE (ALIVAL MERITAL) - ISOLATION AND IDENTIFICATION OF THE CONJUGATES OF NOMIFENSINE-C-14 FROM HUMAN-URINE [J].
HORNKE, I ;
FEHLHABER, HW ;
GIRG, M ;
JANTZ, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (03) :255-264
[6]  
Houston JB, 1982, PHARMACOL THERAPEUT, V15, P521
[7]   KINETICS AND METABOLISM OF NOMIFENSINE IN ANIMALS [J].
KELLNER, HM ;
BAEDER, C ;
CHRIST, O ;
HEPTNER, W ;
HORNKE, I ;
INGS, RMJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 :S109-S116
[8]  
KLIPPERT PJM, 1985, DRUG METAB DISPOS, V13, P97
[9]  
LASSMAN HB, 1984, J CLIN PSYCHIAT, V45, P26
[10]   DISPOSITION OF NOMIFENSINE AFTER ACUTE AND PROLONGED DOSING [J].
LINDBERG, RLP ;
SYVALAHTI, EKG ;
PIHLAJAMAKI, KK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (04) :384-388